CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance lung cancer treatment by investigating the role of endothelial cells in tumor immunity. It focuses on understanding how specific immune markers and metabolic profiles in these cells can influence the effectiveness of immune checkpoint blockade therapies.
Despite decades of research, cancer remains the second leading cause of death globally.
Amongst all cancers, lung cancer is the deadliest in both men and women worldwide.
Immune checkpoint blockade (ICB) recently emerged as promising cancer therapy.
While extremely successful in hematopoietic cancers and melanoma, success in lung cancer is very limited.
We are therefore in desperate need to devise novel treatment strategies.
One approach would involve remodelling the lung cancer immune landscape…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
